Get 20% lifetime commission for referring investors to digrin.com
here.
Cartesian Therapeutics, Inc. ( RNAC) - Stock Earnings
RNAC Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
RNAC Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -92.6 million USD | 947000 USD |
| 2026Q1 | -39.2 million USD | 78000 USD |
| 2026Q2 | 13.7 million USD | — USD |
| 2027Q2 Est. | — | — |
RNAC Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -219.7 million USD | 26.0 million USD |
| 2024 | -77.4 million USD | 38.9 million USD |
| 2025 | -130.3 million USD | 2.8 million USD |
| 2026 Est. | — | — |
RNAC
Price: $6.27
52 week price:
Earnings Per Share: -5.72 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 196.3 million